Peripheral-blood stem cell transplant

Summarized by Plex Health
Last Updated: 07 May 2022

All children and adults with AML who have accomplished a first or 2nd bone marrow remission are qualified for this method; patients have to undergo peripheral blood stem cell collection or marrow harvest while in remission and should not be expected to have better outcomes with allogeneic transplantation; Patients with cytogenetic problems recommending an enhanced prognosis [inv, t and t] will be eligible for transplantation in first remission; Allogeneic transplant with a human leukocyte antigen -identical sibling will be recommended for.

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

** If you believe that content on the Plex is summarised improperly, please, contact us, and we will get rid of it quickly; please, send an email with a brief explanation.

*** If you want us to remove all links leading to your domain from Plex.page and never use your website as a source of the "Online Knowledge", please contact us using a corporate email and we will remove everything in 10 business days.

logo

Plex Page is a Biology & Health Sciences "Online Knowledge Base," where a machine summarizes all the summaries.